The Clorox Company — 5.5/10

HOLD

NYSE: CLX | Dominant share positions in mature household categories — ~61% NA liquid bleach, ~80% charcoal (Kingsford), ~35% ranch (Hidden Valley), ~28% water filtration (Brita). ~80% of sales in #1/#2 positions. Oligopoly gate PASS. But management track record fails (~40-45% hit rate, FY26 guidance cut ~9%, organic growth below 3-5% IGNITE algorithm). Financial trends weak (margins compressing, FCF choppy). Quality gate: PARTIAL PASS (1 NO — management).

Oligopoly Positions

~61% bleach, ~80% charcoal

Gate PASS

FY26 Adj EPS Guide Cut ~9%

$5.45-5.65

Execution miss

Financial Trends 4/10

Margins compressing

Weak

Management 4/10

~40-45% hit rate

Below bar

Company overview

The Clorox Company is a leading manufacturer and marketer of consumer and professional products operating four segments: Health and Wellness (Clorox bleach, Pine-Sol, CloroxPro), Household (Glad trash bags, Kingsford charcoal, Fresh Step cat litter), Lifestyle (Hidden Valley dressings, Brita water filtration), and International. Fiscal year ends June 30. ~80% of revenue comes from brands holding #1 or #2 category positions.

FYE	June 30	Revenue Mix	~80% of sales in #1/#2 positions
FY26Q3 FCF	$311M / 13.3% margin	Organic Growth	Below 3-5% IGNITE target
Quality Gate	PARTIAL PASS (1 NO: management track record)

Quality gate

PARTIAL PASS — One of three criteria not met. Score normally but flag management weakness.

Oligopoly position (>30% share)?	YES — ~61% NA liquid bleach, ~80% charcoal (Kingsford), ~35% ranch dressing (Hidden Valley), ~28% water filtration (Brita). Over 80% of revenue from #1 or #2 category positions.	Positive and growing FCF?	YES — FY26Q3 FCF $311M (13.3% margin). Positive but choppy trajectory across quarters.
Management 3+ year track record?	NO — ~40-45% hit rate on guidance. FY26 EPS guidance cut ~9% ($5.45-5.65). Organic growth consistently below the 3-5% IGNITE algorithm target.

Score breakdown

/ 10

Financial TrendsWeight: 25%

Margins compressing, FCF choppy. Revenue flat to declining over multi-year periods. FY26 EPS guidance cut ~9% reflects ongoing execution challenges. Gross margin recovery from FY22 trough was genuine but now reversing under tariff and input cost pressure.

/ 10

Thematic ExposureWeight: 35%

Genuine #1 positions across multiple household categories. ~61% bleach, ~80% charcoal, ~35% ranch dressing, ~28% water filtration. Oligopoly gate PASS. These are durable, defensible franchises even if low-growth.

/ 10

Management QualityWeight: 20%

~40-45% hit rate on promises and guidance. FY26 EPS guidance cut ~9%. IGNITE 3-5% organic growth algorithm never sustainably delivered. Repeated misses erode credibility despite genuine cost discipline.

/ 10

Investor SentimentWeight: 5%

Negative consensus with limited contrarian edge. Unlike deeply oversold names with clear catalysts, CLX lacks a visible re-rating trigger. Management credibility gap limits upside from sentiment reversal.

/ 10

Concerns / Catalysts / RisksWeight: 15%

Below-peer valuation, zero China exposure, low regulatory risk. Favorable risk profile partially offsets weak financials and management. Tariff exposure manageable given domestic manufacturing footprint.

Dimension	Score	Weight	Weighted
Financial Trends	4	25%	1.00
Thematic Exposure	7	35%	2.45
Management Quality	4	20%	0.80
Investor Sentiment	4	5%	0.20
Concerns / Catalysts / Risks	7	15%	1.05
Composite		100%	5.5

Summary thesis

Dominant household brands in mature, low-growth categories that clear the oligopoly gate. But financial trends are weak (margins compressing, FCF choppy), management has missed its own guidance repeatedly (~40-45% hit rate, FY26 EPS cut), and there is no contrarian edge. The thematic strength (7/10 -- genuine #1 positions) and favorable risk profile (7/10 -- below-peer valuation, zero China, low regulatory risk) partially offset.

Quality gate: PARTIAL PASS (1 NO). Oligopoly YES, positive/growing FCF YES, management track record NO.

What to watch

FY26 Q4 earnings -- final quarter of fiscal year; watch for margin trajectory and whether organic growth shows any recovery toward the IGNITE 3-5% target
FY27 guidance -- management credibility test; after cutting FY26 EPS ~9%, the FY27 outlook will signal whether execution is improving or structural challenges persist
GOJO/Purell integration -- health/hygiene growth vector; monitor for revenue contribution and margin impact
Tariff evolution -- manageable today given domestic manufacturing, but escalation could compress margins further
Category growth rates -- 0-1% underlying growth vs 2-2.5% historical norm; any acceleration would support the bull case

Re-score trigger: Two consecutive quarters of organic growth above 3% with stable or expanding margins, combined with management hitting guidance, would warrant a move to 6.0+.

Data sourced from Daloopa (company_id: 325). Analysis date June 27, 2026.